Who
Zachary Scheiner
Director
Company insider
Files Form 4 as: Director, LENZ Therapeutics; Director, Nkarta; Director, SpyGlass Pharma.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 9 Jul 2020
- Last trade
- 15 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 15 Jun 2026 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,100 at $0.00 | filing |
| 15 Jun 2026filed 15 Jun 2026 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,100 at $0.00 | filing |
| 10 Jun 2026filed 11 Jun 2026 | NKTX Nkartaoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,000 at $0.00 | filing |
| 10 Jun 2026filed 11 Jun 2026 | NKTX Nkartaoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,000 at $0.00 | filing |
| 5 Feb 2026filed 9 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code A | —27,400 at $0.00 | filing |
| 5 Feb 2026filed 9 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code A | —27,400 at $0.00 | filing |
| 11 Jun 2025filed 11 Jun 2025 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,500 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | NKTX Nkartaoption or derivative · Biotechnology | SEC FORM 4 Code A | —46,000 at $0.00 | filing |
| 13 Jun 2024filed 14 Jun 2024 | NKTX Nkartaoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 21 Mar 2024filed 25 Mar 2024 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 7 Jun 2023filed 9 Jun 2023 | NKTX Nkartaoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 8 Jun 2022filed 10 Jun 2022 | NKTX Nkartaoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 13 Jun 2021filed 15 Jun 2021 | NKTX Nkartaoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,511 at $0.00 | filing |
| 9 Jul 2020filed 13 Jul 2020 | NKTX Nkartaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,700 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.